{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:44:01Z","timestamp":1793421841860,"version":"4.5.0"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.amjcard.2020.05.020","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:54:18Z","timestamp":1589630058000},"page":"1-4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry)"],"prefix":"10.1016","volume":"129","author":[{"given":"Katelyn M.","family":"Storey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross F.","family":"Garberich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel M.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Traverse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa L.","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9333-1620","authenticated-orcid":false,"given":"Christian W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy D.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2020.05.020_bib0001","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.05.020_bib0002","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ahj.2007.12.004","article-title":"Clinical and research issues regarding chronic advanced coronary artery disease: part I: contemporary and emerging therapies","volume":"155","author":"Jolicoeur","year":"2008","journal-title":"Am Heart J"},{"issue":"suppl 2","key":"10.1016\/j.amjcard.2020.05.020_bib0003","first-page":"S50","article-title":"Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification","volume":"28","author":"Jolicoeur","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2020.05.020_bib0004","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrcardio.2013.200","article-title":"Treatment of refractory angina in patients not suitable for revascularization","volume":"11","author":"Henry","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.amjcard.2020.05.020_bib0005","unstructured":"Povsic TJ, Henry TD, Ohman EM. Therapeutic approaches for the \u201cNo-Option\u201d refractory angina patient. (CIRC Intervention, in press)."},{"key":"10.1016\/j.amjcard.2020.05.020_bib0006","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1060028017747901","article-title":"Efficacy and safety of Ranolazine in diabetic patients: a systematic review and meta-analysis","volume":"52","author":"Zeng","year":"2018","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjcard.2020.05.020_bib0007","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/HPC.0000000000000022","article-title":"Ranolazine refractory angina registry: 1-year results","volume":"13","author":"Bennett","year":"2014","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.amjcard.2020.05.020_bib0008","first-page":"1215","article-title":"Revascularization in \"no option\" patients with refractory angina: Frequency, etiology and outcomes","volume":"92","author":"Sharma","year":"2018","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920304963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920304963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:34:35Z","timestamp":1757572475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914920304963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":8,"alternative-id":["S0002914920304963"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.05.020","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}